SINGAPORE, Aug. 18, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today announced that its BCM3 dual-function production line for...
Hence then, the article about wuxi xdc achieves gmp release of bcm3 facility at singapore site enabling global clients with professional excellence was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence )
Also on site :
- Child Psychologists Are Begging Parents and Grandparents To Stop Asking Kids This Question (and What To Ask Instead)
- Hayden Panettiere planned to see daughter Kaya, 11, in Ukraine before star’s death: ‘She loved her so much’
- CATL und Quinbrook bauen ihre Supernode-Partnerschaft nach wichtigen Meilensteinen in den Phasen 2 und 3 weiter aus